Hologic (NASDAQ:HOLX) Reaches New 52-Week High at $56.28

Shares of Hologic, Inc. (NASDAQ:HOLX) reached a new 52-week high during trading on Tuesday . The stock traded as high as $56.28 and last traded at $56.23, with a volume of 68518 shares. The stock had previously closed at $53.33.

Several research analysts recently commented on HOLX shares. Raymond James raised shares of Hologic from a “market perform” rating to an “outperform” rating and set a $62.00 price target on the stock in a research note on Wednesday, June 3rd. Cowen raised shares of Hologic from a “market perform” rating to an “outperform” rating and set a $64.00 price target on the stock in a research note on Tuesday. Stifel Nicolaus reduced their price target on shares of Hologic from $52.00 to $45.00 and set a “hold” rating on the stock in a research note on Wednesday, April 8th. JPMorgan Chase & Co. increased their target price on shares of Hologic from $45.00 to $55.00 and gave the stock an “overweight” rating in a report on Thursday, April 30th. Finally, Needham & Company LLC reiterated a “buy” rating on shares of Hologic in a report on Wednesday, June 10th. One research analyst has rated the stock with a sell rating, seven have given a hold rating and twelve have assigned a buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and an average price target of $56.83.

The firm has a market capitalization of $13.82 billion, a P/E ratio of 24.55, a PEG ratio of 3.28 and a beta of 1.44. The company has a debt-to-equity ratio of 1.32, a quick ratio of 1.04 and a current ratio of 1.31. The business’s fifty day moving average price is $52.69 and its two-hundred day moving average price is $48.88.

Hologic (NASDAQ:HOLX) last released its quarterly earnings results on Wednesday, April 29th. The medical equipment provider reported $0.57 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.57. Hologic had a net margin of 18.53% and a return on equity of 30.49%. The business had revenue of $756.10 million for the quarter, compared to analysts’ expectations of $756.10 million. During the same period last year, the business earned $0.58 EPS. Sell-side analysts predict that Hologic, Inc. will post 2.32 earnings per share for the current year.

In related news, General Counsel John M. Griffin sold 4,906 shares of the stock in a transaction that occurred on Tuesday, April 28th. The shares were sold at an average price of $50.00, for a total value of $245,300.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Stephen P. Macmillan sold 190,996 shares of the stock in a transaction that occurred on Wednesday, May 13th. The shares were sold at an average price of $50.97, for a total transaction of $9,735,066.12. The disclosure for this sale can be found here. Insiders sold a total of 238,345 shares of company stock valued at $12,185,194 over the last ninety days. 1.00% of the stock is currently owned by insiders.

Institutional investors have recently made changes to their positions in the stock. Sunbelt Securities Inc. purchased a new position in shares of Hologic in the 4th quarter valued at approximately $6,526,000. Ancora Advisors LLC purchased a new position in Hologic during the 4th quarter worth approximately $39,000. Signaturefd LLC raised its position in Hologic by 67.4% during the 1st quarter. Signaturefd LLC now owns 792 shares of the medical equipment provider’s stock worth $28,000 after buying an additional 319 shares during the last quarter. Total Clarity Wealth Management Inc. purchased a new position in Hologic during the 4th quarter worth approximately $45,000. Finally, CWM LLC raised its position in Hologic by 63.4% during the 1st quarter. CWM LLC now owns 910 shares of the medical equipment provider’s stock worth $32,000 after buying an additional 353 shares during the last quarter. 92.45% of the stock is owned by hedge funds and other institutional investors.

Hologic Company Profile (NASDAQ:HOLX)

Hologic, Inc, a medical technology company, develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women in the United States, Europe, the Asia-Pacific, and internationally. It operates in five segments: Diagnostics, Breast Health, Medical Aesthetics, GYN Surgical, and Skeletal Health.

Read More: Quick Ratio

Receive News & Ratings for Hologic Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hologic and related companies with MarketBeat.com's FREE daily email newsletter.